Suven Pharmaceuticals Ltd.
Share Price Target & Analysis
NSE:SUVENPHAR
VWAP
Open
Close
High
Low
52 Week High
-4.45 (-1.17%)
SUVENPHAR
(PHARMA)Watch Carefully
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: SUVENPHAR Share Price Financial Analysis & Valuation
Suven Pharmaceuticals Ltd. (SUVENPHAR) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Mid Cap company with Market Capitalization of Rs 12743.7 (in Cr). Total number of free float shares are 0 (in Lacs).
Suven Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE03QK01018 and trading code is NSE:SUVENPHAR with short name Cohance Life.
In the past 1 year, Suven Pharmaceuticals Ltd. has declared an equity dividend of Rs 0 per share. At the current share price of SUVENPHAR at Rs 376.20, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:SUVENPHAR, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine SUVENPHAR underlying value and future prospects. All of this data is available in SUVENPHAR financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:SUVENPHAR, it is clearly understood that SUVENPHAR is Economical performer in terms of earnings and profit margins with an EPS of 11.05. NSE:SUVENPHAR book value per share as of today is 115.25. The current price to book ratio for SUVENPHAR as of Sep 07, 2026 is 3.26.
Valuation of the Stock: The current valuation of SUVENPHAR stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of SUVENPHAR whether to BUY this stock at current valuation. The delivery percentage of SUVENPHAR is 42.69% is very crucial parameter which shows that 42.69% investors are anticipating that the price of SUVENPHAR share should go up with VWAP at 376.7.
Now, the main question is whether to BUY or SELL, NSE:SUVENPHAR at current valuation.
As per latest Analysis No. #1615:-
⇑ STRONG BUY SUVENPHAR if All Greens
⇗ BUY SUVENPHAR (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD SUVENPHAR (With Stop Loss) if only 1 Green
⇘ SELL SUVENPHAR if NO Green Indicator
NSE: SUVENPHAR Share Price Today (Sep 07, 2026)
(Suven Pharmaceuticals Ltd. Daily Analysis on the basis of SUVENPHAR Intraday Graph & Trend)
Suven Pharmaceuticals Ltd. share price moved Down by -1.17% from its previous close of Rs 380.65. SUVENPHAR stock last traded price is 376.20. SUVENPHAR share price trend is Down with a total of 17947 stocks traded till now. It has touched an intraday high of Rs 379 and an intraday low of Rs 374.3. The SUVENPHAR trading at 376.20, Down by Rs. -4.45, or -1.17 percent which suggests that most of the Traders are anticipating that the price of SUVENPHAR share should go Down.
NSE: SUVENPHAR Share Price Tomorrow Prediction
(Suven Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of SUVENPHAR)
Suven Pharmaceuticals Ltd. share price moved Down by -1.17%. SUVENPHAR share price short term trend is Down. It suggests that SUVENPHAR Share Price for Tomorrow remains the same with VWAP at 376.7 will be treated as stop loss for intraday traders. Suven Pharmaceuticals Ltd. Long term investors can follow the SUVENPHAR long term trend as mentiond in future forecast table.
NSE Code |
NSE: SUVENPHAR |
SUVENPHAR Share Price Today |
376.20 |
SUVENPHAR Share Price Target Prediction for 2026 ^ |
372.9 - 896.7 |
SUVENPHAR Share Price Target Prediction for 2027*^ |
896.7 - 1421.8 |
SUVENPHAR Share Price Target Prediction for 2028*^ |
1421.8 - 1521.3 |
SUVENPHAR Share Price Target Prediction for 2029*^ |
1597 |
SUVENPHAR Share Price Target Prediction for 2030*^ |
1643 |
SUVENPHAR Share Price Target Prediction for 2035*^ |
1791 |
| SUVENPHAR Current Book Value |
114.7 |
*Suven Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^SUVENPHAR share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
SUVENPHAR Technical Analysis (In Process... .. .)
Please wait for a while and refresh the page to check again.
Most popular Questions & Answers about SUVENPHAR (/ FAQ SUVENPHAR)
Suven Pharmaceuticals Ltd. stock last traded price is 376.20. SUVENPHAR share price moved Down by -1.17% from its previous close of Rs 380.65.
Suven Pharmaceuticals Ltd. share price trend is Down with a total of 17947 stocks traded till now. It has touched an intraday high of Rs 1341.28 and an intraday low of Rs 374.3. The SUVENPHAR trading at 376.20, Down by Rs. -4.45, or -1.17 percent which suggests that most of the Traders are anticipating that the price of SUVENPHAR share should go Down and the Stop Loss will be around 376.7.
The market cap of Suven Pharmaceuticals Ltd. is ₹12743.7 (in Cr) as of Sep 06, 2026.
The current price to earning ratio for Suven Pharmaceuticals Ltd. as of Sep 06, 2026 is 43.61.
The current price to book ratio for Suven Pharmaceuticals Ltd. as of Sep 06, 2026 is 3.26.
The highest price of Suven Pharmaceuticals Ltd. stock is ₹1328 in the last 52-week.
The lowest price of Suven Pharmaceuticals Ltd. stock is ₹355.7 in the last 52-week.
Suven Pharmaceuticals Ltd. share trading at ₹376.20, Down by Rs. -4.45, or -1.17 percent which suggests that most of the traders are anticipating that the price of SUVENPHAR share should go Down.
In 2026, Stock price target for Suven Pharmaceuticals Ltd. (SUVENPHAR) will be around ₹372.9 on downside and ₹896.7 on upside. Suven Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.
In 2027, Stock price target for Suven Pharmaceuticals Ltd. (SUVENPHAR) will be around ₹896.7 on downside and ₹1421.8 on upside. Suven Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Suven Pharmaceuticals Ltd. (SUVENPHAR) will be around ₹1421.8 on downside and ₹1521.3 on upside. Suven Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Suven Pharmaceuticals Ltd. (SUVENPHAR) will be around ₹1643 Suven Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of SUVENPHAR.
The price of Suven Pharmaceuticals Ltd. (SUVENPHAR) shares moved by -1.17%. The short-term trend for SUVENPHAR share price is Down. It implies that the share price of SUVENPHAR will stay the same tomorrow and that intraday traders should treat VWAP at 376.7 as a stop loss. Investors with a long-term outlook can track SUVENPHAR long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of SUVENPHAR stock is 132.5. Compared to the current market price of 376.20 INR, the SUVENPHAR stock is Overvalued by 64.8%.
As per the fundamental analysis of Suven Pharmaceuticals Ltd. (SUVENPHAR), it is of Economical quality in terms of earnings and profit margins with an EPS of 11.05. Suven Pharmaceuticals Ltd. book value per share as of today is 115.25. The current price to book ratio for SUVENPHAR as of Sep 07, 2026 is 3.26.
NSE:SUVENPHAR News & Other Useful Information about SUVENPHAR Share Price
Peer Comparison of NSE: SUVENPHAR
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1120.00 | 34.93 | 238.63 |
| GLAND | 2932.40 | 84.54 | 677.38 |
| CADILAHC | 905.25 | 46.9 | 215.08 |
| MADHAVBAUG | 148.00 | 4.69 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1321.70 | 13.88 | 234.07 |
| PGHL | 5660.00 | 215 | 373.93 |
| SYMBIOTEC | 1078.25 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 852.85 | 24.65 | 151.81 |
| SIGACHI | 32.55 | 0.68 | 12.62 |
| SAKAR | 1006.95 | 16.22 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 0.00 | 0 | 0 |
| JSLL | 501.45 | 19.03 | 42.89 |
| JFLLIFE | 0.00 | 0 | 0 |
| MANKIND | 2327.90 | 52.8 | 410.55 |
| SOTAC | 0.00 | 0 | 0 |
| REMUS | 0.00 | 0 | 0 |
| VILINBIO | 18.00 | 1.26 | 18.6 |
| SAROJA | 41.00 | 4.01 | 43 |
| VALIANTLAB | 100.93 | 2.43 | 60.62 |
| BLUEJET | 569.80 | 13.54 | 82.91 |
| ACCENTMIC | 286.90 | 18.28 | 114.84 |
| ZENITHDRUG | 0.00 | 0 | 0 |
| INNOVACAP | 1175.40 | 16.68 | 160.54 |
| ENTERO | 1827.60 | 0 | 387.5 |
| EMCURE | 1854.70 | 42.72 | 206.18 |
| MEDIORG | 0.00 | 0 | 0 |
| AKUMS | 765.75 | 10.26 | 157.14 |